Protein Target for Anti-Viral Drug Found
Posted on: Tuesday, 30 May 2006, 18:00 CDT
U.S. researchers say they have used small molecules containing platinum to inhibit proteins important in the development of HIV and cancer.
The researchers at Virginia Commonwealth University's Massey Cancer Center in Richmond, Va., say the findings may help researchers develop new drugs to fight HIV or cancer by selectively targeting proteins known as zinc fingers.
The scientists say a zinc finger protein, HIV NCp7, can be inhibited when exposed to a platinum complex, with the zinc portion of the molecule being ejected from the protein chain. That causes the protein to lose its tertiary structure or overall shape. For the molecules, shape is an important property that enables the protein to carry out certain biological functions.
The process -- active site displacement -- involved design of a platinum drug with higher affinity for the protein peptide backbone, thus eliminating the zinc from its active site.
The researchers say they believe if they can inhibit the action of the zinc finger protein, they can stop the spread of the virus.
The study appears in the journal Chemistry & Biology.
Source: United Press International
Related Articles
- Prebiotics Add Heart-Health, Bone-Health and Digestive-Health Support to Research-Proven Cancer Fighting Ability
- A protein key to making a cancer invasive
- Targeting Helpers Of Heat Shock Proteins May Help Treat Cancer, Cardiovascular Disease
- Researchers Say More Aggressive Vitamin D Supplementation Needed in Obese Cancer Patients
- Two Targeted Therapies Likely Better Than One in Patients with Aggressive Lymphoma, Mayo Clinic Researchers Say
- Protein May Aid Breast Cancer Growth
- Protein Can Predict Rate of HIV Infection
- HIV Protein Key to New Cancer Therapy
- Researchers Say Low-Cal Diet Cuts Aging
- Proteins Show Promise As Cancer Treatment Tool; Proteomics Also Could Help Guide Cancer Drug Development, Study Finds
 |
 |
User Comments (0)
RSS Feeds